Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ala-Eddine Deghmane

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
NPJ Vaccines|June 29, 2022
Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in FranceSamy Taha, Muhamed-Kheir Taha, Ala-Eddine Deghmane
The Journal of Antimicrobial Chemotherapy|November 27, 2024
Meningococcal resistance to ciprofloxacin is not rare anymoreAla-Eddine Deghmane, Samy Taha, Muhamed-Kheir Taha
Vaccines|September 27, 2025
Multi-Component Vaccine Candidates Against Non-Typeable <i>Haemophilus influenzae</i>Nouria Belkacem, Ala-Eddine Deghmane, Muhamed-Kheir Taha
BMC Infectious Diseases|June 26, 2024
Recent increase in atypical presentations of invasive meningococcal disease in FranceSamy Taha, Ala-Eddine Deghmane, Muhamed-Kheir Taha
Methods in Molecular Biology (Clifton, N.J.)|April 7, 2009
Detection of activated Rab7 GTPase with an immobilized RILP probeJim Sun, Ala-Eddine Deghmane, Cecilia Bucci, et al.
Expert Opinion on Emerging Drugs|July 24, 2009
Emerging drugs for acute bacterial meningitisAla-Eddine Deghmane, Jean-Michel Alonso, Muhamed-Kheir Taha
Vaccine|November 6, 2012
Functional impacts of the diversity of the meningococcal factor H binding proteinEva Hong, Dario Giorgini, Ala-Eddine Deghmane, et al.
BMC Infectious Diseases|June 3, 2014
Lipocalin 2 in cerebrospinal fluid as a marker of acute bacterial meningitisTamazoust Guiddir, Ala-Eddine Deghmane, Dario Giorgini, et al.
Journal of Global Antimicrobial Resistance|October 4, 2022
Haemophilus influenzae drug resistance in France from 2017 to 2021: consideration for treatment of otitis mediaAnas Taha, Florence Adeline, Muhamed-Kheir Taha, et al.
Human Vaccines & Immunotherapeutics|March 27, 2020
Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countriesMuhamed-Kheir Taha, Joël Gaudelus, Ala-Eddine Deghmane, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
NPJ Vaccines|June 29, 2022
Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in FranceSamy Taha, Muhamed-Kheir Taha, Ala-Eddine Deghmane
The Journal of Antimicrobial Chemotherapy|November 27, 2024
Meningococcal resistance to ciprofloxacin is not rare anymoreAla-Eddine Deghmane, Samy Taha, Muhamed-Kheir Taha
Vaccines|September 27, 2025
Multi-Component Vaccine Candidates Against Non-Typeable <i>Haemophilus influenzae</i>Nouria Belkacem, Ala-Eddine Deghmane, Muhamed-Kheir Taha
BMC Infectious Diseases|June 26, 2024
Recent increase in atypical presentations of invasive meningococcal disease in FranceSamy Taha, Ala-Eddine Deghmane, Muhamed-Kheir Taha
Methods in Molecular Biology (Clifton, N.J.)|April 7, 2009
Detection of activated Rab7 GTPase with an immobilized RILP probeJim Sun, Ala-Eddine Deghmane, Cecilia Bucci, et al.
Expert Opinion on Emerging Drugs|July 24, 2009
Emerging drugs for acute bacterial meningitisAla-Eddine Deghmane, Jean-Michel Alonso, Muhamed-Kheir Taha
Vaccine|November 6, 2012
Functional impacts of the diversity of the meningococcal factor H binding proteinEva Hong, Dario Giorgini, Ala-Eddine Deghmane, et al.
BMC Infectious Diseases|June 3, 2014
Lipocalin 2 in cerebrospinal fluid as a marker of acute bacterial meningitisTamazoust Guiddir, Ala-Eddine Deghmane, Dario Giorgini, et al.
Journal of Global Antimicrobial Resistance|October 4, 2022
Haemophilus influenzae drug resistance in France from 2017 to 2021: consideration for treatment of otitis mediaAnas Taha, Florence Adeline, Muhamed-Kheir Taha, et al.
Human Vaccines & Immunotherapeutics|March 27, 2020
Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countriesMuhamed-Kheir Taha, Joël Gaudelus, Ala-Eddine Deghmane, et al.
Pageof 12